C h a p t e r 4 6
Disorders of Skin Integrity and Function
1183
14. Forbes HJ, Thomas SL, Langan SM. The epidemiology and
prevention of herpes zoster.
Curr Dermatol Rep.
2012;1:39–47.
15. Tseng HF, Smith N, Harpaz R, et al. Herpes zoster vaccine in
older adults and the risk of subsequent herpes zoster disease.
JAMA.
2011;305(2):160–166.
16. Goldman GS, King PG. Review of the United States universal
varicella vaccination program: herpes zoster incidence rates,
cost effectiveness, and vaccine efficacy based primarily on the
Antelope Valley Varicella Active Surveillance Project Data.
Vaccine.
2013;31(13):1680–1694.
17. Ramli R, Malik AS, Hani AFH, et al. Acne analysis, grading
and computational assessment methods: an overview.
Skin Res
Technol.
2012;18:1–14.
18. Archer CB, Cohen SN, Baron SE. Guidance on the diagnosis and
clinical management of acne.
Clin Exp Dermatol.
2012;37:1–6.
19. Steventon K. Expert opinion and review article: the timing of
comedone extraction in the treatment of premenstrual acne—a
proposed therapeutic approach.
Int J Cosmet Sci.
2010;33:99–104.
20. Perkins AC, Maglione J, Hillebrand GG, et al. Acne vulgaris
in women: prevalence across the lifespan.
J Womens Health.
2010;21(2):223–230.
21. Jahns AC, Lundskog B, Ganceviciene R, et al. An increased
incidence of
Propionibacterium acnes
biofilms in acne vulgaris:
a case-control study.
Br J Dermatol.
2012;167:150–158.
22. Kurokawa I, Danby W, Ju Q, et al. New developments in
our understanding of acne pathogenesis and treatment.
Exp
Dermatol.
2009;18:821–832.
23. Shah SK, Alexis AF. Acne in skin color: practical approaches to
treatment.
J Dermatolog Treat.
2010;21:206–211.
24. Chauhan N, Ellis DA. Rosacea: pathophysiology and
management principles.
Facial Plast Surg Clin North Am.
2013;21(1):127–136.
25. Torpy JM, Schwartz LA, Golub RM. Rosacea.
JAMA.
2012;307(21):3942.
26. van Zuuren EJ, Kramer SF, Carter BR, et al. Effective
and evidence-based management strategies for rosacea:
summary of a Cochrane systematic review.
Br J Dermatol.
2011;165:760–781.
27. Rustemeyer T, van Hoogstraten MW, von Blomberg
BME, et al. Mechanisms of irritant and allergic contact
dermatitis. In: Johansen JD, Frosh PJ, Lepoittevin JP, eds.
Contact Dermatitis
. 5th ed. Dortmund, Germany: Springer;
2011:43–90.
28. Goodheart HP.
Goodheart’s Photoguide to Common Skin
Disorders
. Philadelphia, PA: Wolters Kluwer Health | Lippincott
Williams & Wilkins; 2009:51–59.
29. Cheong WK. Gentle cleansing and moisturizing for patients
with atopic dermatitis and sensitive skin.
Am J Clin Dermatol.
2009;10:13–17.
30. Zitelli KB, Cordoro KM. Evidence-based evaluation and
management of chronic urticaria in children.
Pediatr Dermatol.
2011;28(6):629–639.
31. Axelrod S, Davis-Lorton M. Urticaria and angioedema.
Mt Sinai
J Med.
2011;78:784–802.
32. Sokumbi O, Wetter DA. Clinical features, diagnosis, and
treatment of erythema multiforme: a review for the practicing
dermatologist.
Int J Dermatol.
2012;51:889–902.
33. Diaz L, Ciurea AM. Cutaneous and systemic adverse reactions to
antibiotics.
Dermatol Ther.
2012;25:12–22.
34. Wolff K, Johnson RA, Saavedra AP, eds.
Fitzpatrick’s Color
Atlas and Synopsis of Clinical Dermatology
. 7th ed. Chicago, IL:
McGraw-Hill; 2013:488–507.
35. Khalili R, Bahria SL. Pathogenesis and recent therapeutic trends
in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Ann Allergy Asthma Immunol. 2006;97:272–281.
36. Ziemer M, Kardaun SH, Liss Y, et al. Stevens-Johnson
syndrome and toxic epidermal necrolysis in patients with
lupus erythematosus: a descriptive study of 17 cases from a
national registry and review of the literature.
Br J Dermatol.
2012;166:575–600.
37. Nestle FO, Kaplan DH, Barker J. Psoriasis.
N Engl J Med.
2009;361(15):496–509.
38. Raho G, Koleva DM, Garattini L, et al. The burden of
moderate to severe psoriasis: an overview.
Pharmacoeconomics.
2012;30(11):1005–1013.
39. Cohen SN, Baron SE, Archer CB. Guidance on the diagnosis
and clinical management of psoriasis.
Clin Exp Dermatol.
2012;37:13–18.
40. Herrier RN. Advances in the treatment of moderate-to-severe
plaque psoriasis.
Am J Health Syst Pharm.
2011;68:795–806.
41. Kim IH, West CE, Kwatra SG, et al. Comparative efficacy
of biologics in psoriasis: a review.
Am J Clin Dermatol.
2012;3(6):365–374.
42. Goodheart HP.
Goodheart’s Photoguide to Common Skin
Disorders
. Philadelphia, PA: Wolters Kluwer Health | Lippincott
Williams & Wilkins; 2009:114–118.
43. Lehman JS, Tollefson MM, Gibson LE. Lichen planus.
Int J
Dermatol.
2009;48:682–694.
44. Martin-Brufau R, Corbalan-Berna J, Ramirez-Andreo A, et al.
Personality differences between patients with lichen simplex
chronicus and normal population: a study of pruritus.
Eur J
Dermatol.
2010;20(3):359–363.
45. Galadari HI, Gilchrest BA. Skin cancer prevention and
sunscreens. In: Nouri K, ed.
Skin Cancer
. Chicago, IL: McGraw-
Hill; 2008:643–647.
46. Bouzari N, Nouri K. Indoor tanning. In: Nouri K, ed.
Skin
Cancer
. Chicago, IL: McGraw-Hill; 2008:672–678.
47. Land V, Small L. The evidence on how to best treat sunburn
in children: a common treatment dilemma.
Pediatr Nurs.
2008;34(4):343–348.
48. American Burn Association. Burn incidence and treatment in
the United States: 2012 Fact Sheet. 2012. Available at: http://
ameriburn.org/resources_factsheet.php. Accessed October 5, 2013.
49. Price LA, Milner SM. The totality of burn care.
Trauma.
2012;15(1):16–28.
50. Evers LH, Bhavsar D, Mailander P. The biology of burn injury.
Exp Dermatol.
2010;19:777–783.
51. Orgill DP. Excision and skin grafting of thermal burns.
N Engl J
Med.
2009;360(9):891–901.
52. van der Veen VC, Boekema BKHL, Ulrich MMW, et al. New
dermal substitutes.
Wound Repair Regen.
2011;19:S59–S65.
53. Agency for Healthcare Research and Quality. Preventing
pressure ulcers in hospital: a toolkit for improving quality of
care. 2013. Available at:
/
pressureulcertoolkit. Accessed October 13, 2013.
54. Alderden J, Whitney JD, Taylor SM, et al. Risk profile
characteristics associated with outcomes of hospital-acquired
pressure ulcers: a retrospective review.
Crit Care Nurse.
2011;31(4):30–43.
55. Sprigle S, Sonenblum S. Assessing evidence supporting
redistribution of pressure for pressure ulcer prevention: a review.
J Rehabil Res Dev.
2011;48(3):203–214.
56. Reddy M. Pressure ulcers.
Clin Evid
(Online) 2011:1901.
57. National Pressure Ulcer Advisory Panel. NPUAP pressure ulcer
stages/categories. 2013. Available at:
/
resources/educational-and-clinical-resources/npuap-pressure-
ulcer-stagescategories/. Accessed October 5, 2013.
58. Goodheart HP.
Goodheart’s Photoguide to Common Skin
Disorders
. Philadelphia, PA: Wolters Kluwer Health | Lippincott
Williams & Wilkins; 2009:364–369.
59. Goodheart HP.
Goodheart’s Photoguide to Common Skin
Disorders
. Philadelphia, PA: Wolters Kluwer Health | Lippincott
Williams & Wilkins; 2009:370–374.
60. Clarke LE. Dyplastic nevi.
Clin Lab Med.
2011;31(2):255–265.
